To validate our findings, we examined the SIRT6 expression by immunoblots in benign human prostate tissue (n=7) and prostate cancer tissue (n=7), and found higher SIRT6 levels in prostate cancer tissues than those in normal prostate tissues (Figure S1A). The gene discussed is SIRT6; the disease is prostate carcinoma.